Technology is transforming genetic testing and bringing hope to families facing rare diseases. GeneDx (Nasdaq: WGS) CEO Katherine Stueland sits down with Steve Kraus to share how AI is being used to crack life's most complex code and speed up diagnosis from years to days.

Anne Wojcicki started 23andMe in 2006 to empower consumers with access to their own genetic information. In this episode, she shares the highs and lows of this journey including getting an FDA warning letter, going public, and genotyping over 12 million customers. Plus, she shares why she thinks our healthcare system is a communist system and how genetic relative surprises are remarkably common.